Paradigm Clinical Research Centers, Inc.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis2 trials

Phase

• Phase 22 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• PureTech1 trial
• Vicore Pharma AB1 trial

Running trials

• Active, not recruiting

  A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

  NCT06588686· Phase 2· Vicore Pharma AB· Source

• Active, not recruiting

  LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321420· Phase 2· PureTech· Source